Milestone Pharmaceuticals reported total assets of $181.62M and total liabilities of $163.41M for the quarter ended Jun 2026, up 283.0% year over year. This balance sheet covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 126.40M | 114.14M | 100.20M | 86.20M | 77.20M | 7.64M | 101.00M | 87.60M | 75.70M | 13.76M | 89.50M | 83.30M | 76.40M | 25.31M | 56.00M | 43.40M | 82.60M | 73.05M | 184.20M | 170.60M | ||||||||||||||
| Short-term InvestmentsInvestments (Current) | 15.00M | 8.00M | 23.00M | 39.95M | 56.95M | 27.00M | 55.00M | 65.87M | 52.24M | 79.35M | 69.99M | 63.62M | 44.40M | 10.87M | 0.92M | 35.90M | 32.91M | 112.90M | 0.90M | |||||||||||||||
| Cash & Current Investments | 141.40M | 114.14M | 108.20M | 109.20M | 117.15M | 64.58M | 128.00M | 142.60M | 141.57M | 66.00M | 168.85M | 153.29M | 140.02M | 69.71M | 66.87M | 44.32M | 118.50M | 105.96M | 297.10M | 171.50M | ||||||||||||||
| Receivables - NetNet Receivables | 1.60M | 2.72M | ||||||||||||||||||||||||||||||||
| Receivables - OtherOther Receivables | 0.09M | 0.04M | 0.24M | 0.26M | 0.43M | 0.45M | 0.69M | 1.09M | 1.52M | 1.69M | -1.79M | 1.62M | 1.21M | 0.28M | 1.17M | 0.92M | 0.70M | 0.95M | 1.43M | 0.73M | ||||||||||||||
| Receivables | 3.03M | 3.45M | ||||||||||||||||||||||||||||||||
| Work In Process | 0.52M | 1.61M | 4.34M | |||||||||||||||||||||||||||||||
| Finished Goods | 0.13M | 0.21M | 0.38M | |||||||||||||||||||||||||||||||
| Inventory | 0.65M | 1.83M | 4.72M | |||||||||||||||||||||||||||||||
| Prepaid Assets | 5.97M | 4.30M | 4.07M | 3.46M | 5.06M | 6.00M | 5.45M | 5.40M | 6.96M | 3.18M | 2.36M | 1.71M | 2.52M | 1.84M | 2.36M | 0.75M | 2.58M | 1.80M | 1.21M | 1.03M | ||||||||||||||
| Current Assets | 132.76M | 118.92M | 104.97M | 90.50M | 82.92M | 71.80M | 108.51M | 94.57M | 84.80M | 73.03M | 93.97M | 87.36M | 80.99M | 73.93M | 60.48M | 46.17M | 86.67M | 111.92M | 192.25M | 180.33M | ||||||||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.24M | 0.21M | 0.19M | 0.23M | 0.30M | 0.26M | 0.27M | 0.28M | 0.27M | 0.28M | 0.25M | 0.22M | 0.20M | 0.20M | 0.18M | 0.16M | 0.14M | 0.51M | 0.50M | 0.47M | ||||||||||||||
| Long-Term Deferred Tax | 72.78M | 83.31M | ||||||||||||||||||||||||||||||||
| Non-Current Assets | 1.02M | 0.93M | 0.83M | 0.80M | 2.85M | 2.68M | 2.57M | 2.45M | 2.32M | 2.19M | 2.03M | 1.87M | 1.72M | 1.57M | 1.41M | 1.25M | 1.08M | 1.64M | 1.48M | 1.30M | ||||||||||||||
| Assets | 133.78M | 119.85M | 105.80M | 91.30M | 85.77M | 74.48M | 111.08M | 97.02M | 87.12M | 75.23M | 96.00M | 89.23M | 82.71M | 75.50M | 61.88M | 47.42M | 87.75M | 113.56M | 193.73M | 181.62M | ||||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||||||||
| Accounts Payables | 5.59M | 6.55M | 4.41M | 4.09M | 6.04M | 5.64M | 7.42M | 6.29M | 7.58M | 6.68M | 3.58M | 4.00M | 4.68M | 7.55M | 12.42M | 8.77M | 10.04M | 5.64M | 10.02M | 8.45M | ||||||||||||||
| Payables | 5.59M | 6.55M | 4.41M | 4.09M | 6.04M | 5.64M | 7.42M | 6.29M | 7.58M | 6.68M | 3.58M | 4.00M | 4.68M | 7.55M | 12.42M | 8.77M | 10.04M | 5.64M | 10.02M | 8.45M | ||||||||||||||
| Accumulated Expenses | 1.02M | 1.46M | 0.53M | 0.53M | 1.85M | 2.57M | 1.08M | 1.89M | 2.43M | 0.71M | 0.82M | 1.42M | 1.99M | 2.50M | 1.16M | 2.03M | 2.41M | 7.64M | 9.80M | 11.98M | ||||||||||||||
| Other Accumulated Expenses | 0.34M | 0.44M | 0.39M | 1.09M | 0.76M | 0.26M | 0.55M | 0.64M | 1.25M | 0.25M | 0.47M | 0.31M | 0.38M | 0.48M | 0.38M | 0.24M | 0.52M | 0.49M | 0.83M | 1.20M | ||||||||||||||
| Current Leases | 0.25M | 0.22M | 0.20M | 0.17M | 0.49M | 0.49M | 0.51M | 0.52M | 0.53M | 0.55M | 0.56M | 0.57M | 0.58M | 0.57M | 0.54M | 0.52M | 0.48M | 0.65M | 0.66M | 0.67M | ||||||||||||||
| Current Taxes | ||||||||||||||||||||||||||||||||||
| Current Deferred Revenue | 0.42M | 1.03M | ||||||||||||||||||||||||||||||||
| Total Current Liabilities | 5.85M | 6.78M | 4.61M | 4.26M | 6.52M | 6.14M | 7.96M | 6.81M | 8.11M | 7.23M | 4.13M | 4.57M | 5.26M | 8.13M | 12.96M | 9.28M | 10.52M | 13.98M | 20.94M | 22.18M | ||||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||||||||
| Non-Current Debt | 47.32M | 48.07M | 48.91M | 49.77M | 50.64M | 51.53M | 52.43M | 53.35M | 54.29M | 55.24M | 56.21M | 57.19M | 58.19M | 59.21M | ||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||||||||||
| Operating Leases | 0.51M | 0.47M | 0.43M | 0.38M | 2.09M | 2.00M | 1.86M | 1.73M | 1.58M | 1.46M | 1.31M | 1.16M | 1.00M | 0.87M | 0.76M | 0.64M | 0.52M | 0.54M | 0.37M | 0.19M | ||||||||||||||
| Other Non-Current Liabilities | 52.93M | 52.94M | 52.94M | 52.94M | 52.94M | 34.35M | 48.46M | 48.46M | 48.46M | 48.46M | 53.08M | 53.08M | 53.08M | 53.08M | 53.08M | 53.08M | 55.65M | 55.65M | 55.65M | 55.65M | ||||||||||||||
| Total Non-Current Liabilities | -46.57M | -45.69M | -47.90M | -48.30M | -44.33M | -26.22M | 8.69M | 8.15M | 10.15M | 10.00M | 3.00M | 4.18M | 5.62M | 9.28M | 14.93M | 12.09M | 11.60M | 16.14M | 102.04M | 107.76M | ||||||||||||||
| Total Liabilities | 6.36M | 7.25M | 5.04M | 4.64M | 8.61M | 8.13M | 57.15M | 56.61M | 58.61M | 58.45M | 56.08M | 57.25M | 58.69M | 62.35M | 68.01M | 65.16M | 67.25M | 71.79M | 157.69M | 163.41M | ||||||||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||||||||
| Total Debt | 47.32M | 48.07M | 48.91M | 49.77M | 50.64M | 51.53M | 52.43M | 53.35M | 54.29M | 55.24M | 56.21M | 57.19M | 58.19M | 59.21M | ||||||||||||||||||||
| Common Equity | 127.42M | 112.60M | 100.76M | 86.66M | 77.16M | 66.35M | 53.94M | 40.41M | 28.50M | 16.77M | 39.92M | 31.98M | 24.01M | 13.15M | -6.12M | -17.75M | 20.50M | 41.77M | 36.05M | 18.22M | ||||||||||||||
| Liabilities and Shareholders Equity | 133.78M | 119.85M | 105.80M | 91.30M | 85.77M | 74.48M | 111.08M | 97.02M | 87.12M | 75.23M | 96.00M | 89.23M | 82.71M | 75.50M | 61.88M | 47.42M | 87.75M | 113.56M | 193.73M | 181.62M | ||||||||||||||
| Retained Earnings | -189.44M | -207.95M | -220.33M | -237.00M | -251.53M | -266.34M | -281.30M | -297.33M | -312.42M | -326.03M | -336.40M | -345.74M | -355.20M | -367.55M | -388.31M | -401.30M | -413.20M | -430.60M | -456.70M | -485.30M | ||||||||||||||
| Treasury Shares |